Skip to main content
BEAM logo

BEAM

Beam Therapeutics Inc.
$30.84 -0.05 (-0.16%) At close · Jul 15
Market Cap
$2.92B
Shares
102,879,214

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$30.84 Open$30.54 Day$30.15–31.30 52W$15.60–38.26 Avg vol 30d2.4M Short int22.9M · 22.2% float · 8.4d Short vol79% Last earningsFeb 24, 2026 DataFeb 2020–Jul 2026 Filing10-Q · May 7
Up next
Next earnings call
Jun 15, 2027 Est · unconfirmed · in 48 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 7, 2026
Equibles Rating blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.67
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +10%
above
Price vs 50-day avg −3%
below
RSI (14) 43
neutral
MACD trend Negative
52-week position 67%
mid-range
Momentum
relative strength
Neutral
1-month return −1%
trailing
6-month return −1%
trailing
YTD return +11%
this year
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $32 › 200d $28 — 50d above 200d
Institutional flow Distributing
16 of 253 funds reported for Jun 30 · net -45.5K sh shares · +5 new
Insider flow Distributing
Net -$10.0M over 90 days · 100% sells
Short interest Falling
22.24% of float · ▼ -19.2% MoM · 8.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
253 holders — near 3-yr high, broad support
Squeeze score 67
elevated · 0–100
Fundamentals
Strong
Revenue growth +33%
Y/Y
EPS growth +82%
Y/Y
Free cash flow $-360.0M
Balance sheet $294.9M
net cash
Quant / Vol
risk profile
Very High
Volatility 74%
annualized · 1-yr
Max drawdown −38%
past year
ATR 8.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+10% Bullish
Price vs 50-day avg
−3% Neutral
RSI (14)
43 Neutral
MACD trend
Negative Bearish
52-week position
67% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $32 › 200d $28 — 50d above 200d
Institutional flow Distributing
16 of 253 funds reported for Jun 30 · net -45.5K sh shares · +5 new
Insider flow Distributing
Net -$10.0M over 90 days · 100% sells
Short interest Falling
22.24% of float · ▼ -19.2% MoM · 8.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
253 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $16 Now $31 · 67% 52-wk high $38
vs 200-day avg +10% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings
Metric Latest Period YoY
Cash, cash equivalents and marketable securities 1.2B Q1 2026

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BEAM
Beam Therapeutics Inc.
this stock
$2.92B +11.3% +33.3% 22.2%
ONC
BeOne Medicines Ltd.
$458.76B +2.5% +22179.2% 933.6 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
$123.36B +5.2% +46.2% 28.8 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
$71.18B -13.8% +20.8% 16.6 3.3%
ARGX
Argenx SE
$53.68B +2.6% 2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
255
% held
101.6%
Reported
16 of 253
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
233
View
Short & Settlement
Short Interest Falling
Shares short
22.9M
Days to cover
8.4d
Change
-5.4M sh
View
Short Volume
Short vol %
79%
As of
Jul 16, 2026
Short Total
View
Fails to Deliver
FTD shares
3.0K
Value
$106.4K
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
43.0%
Week of
May 4, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$10.0M
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$139.7M
Net income (FY)
$-80.0M
EPS diluted
$-0.81
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 8, 2026
This year
10
View
Proposed Sales
Value
$857.7K
Shares
25.0K
Filed
Jun 30, 2026
View
Earnings & Events
Earnings Calls
Last call
Feb 24, 2026
View

Performance

5D 20D 120D MTD YTD
BEAM -16.4% -0.9% -0.9% -10.1% +11.3%
SPY +1.3% -0.2% +10.1% +1.1% +10.7%
vs SPY -17.6% -0.7% -11.0% -11.2% +0.6%
Key facts CIK 1745999 CUSIP 07373V105 13F (30d) 16 filings 14 filers Visit website Investor relations